Douglas R Stack

age ~55

from Fishers, IN

Get Report

Also known as:

Douglas J Stack
Doug Stack
Douglas Sack

Phone and address:: 12269 Cobblestone Dr, Fishers, IN 46038
(317)5859157

Connected to:

Douglas Stack Phones & Addresses

12269 Cobblestone Dr, Fishers, IN 46038 • (317)5859157
9755 Overcrest Dr, Fishers, IN 46038 • (317)5859157
135 Clubhouse Dr S, Westfield, IN 46074
Sardis, OH
Indianapolis, IN
Marietta, OH
12269 Cobblestone Dr, Fishers, IN 46037

Work

Position:

Protective Service Occupations

Education

Degree:

Graduate or professional degree

Specialities

Family Practice • Real Estate Litigation • Probate • Municipal Law • Government-All Levels • Government and Administrative Practice • Senior Lawyers

Lawyers & Attorneys

Douglas Stack - Lawyer

view source

Office:

Douglas L. Stack

Specialties:

Family Practice
Real Estate Litigation
Probate
Municipal Law
Government-All Levels
Government and Administrative Practice
Senior Lawyers

ISLN:

903493060

Admitted:

1980

University:

University of Nebraska, B.S., 1976

Law School:

University of Nebraska, J.D., 1980

Resumes

Consultant Chemist, Organic

view source

Location:

12269 Cobblestone Dr, Fishers, IN 46037

Industry:

Pharmaceuticals

Work:

Eli Lilly and Company
Consultant Chemist, Organic

Education:

Marietta College 1988 - 1992
Bachelors, Bachelor of Science, Chemistry

Douglas Stack

view source

Douglas Stack

view source

Skills:

Bakery
Stack
Csg
Distribution
Food

License Records

Douglas Christopher Stack

Phone:

(401)3187825 (Work)

License #:

ALRA00228 - Active

Category:

Assisted Living Residence

Issued Date:

Nov 9, 2005

Expiration Date:

Jun 30, 2018

Type:

Assisted Living Residence Administrator

Douglas Christopher Stack

Phone:

(401)3187825 (Work)

License #:

NHA01033 - Active

Category:

Nursing Home Administrator

Issued Date:

Dec 18, 2008

Expiration Date:

Jun 30, 2018

Type:

Nursing Home Administrator

Douglas Christopher Stack

License #:

ALRA00228 - Active

Category:

Assisted Living Residence

Issued Date:

Sep 11, 2005

Expiration Date:

Jun 30, 2018

Type:

Assisted Living Residence Administrator

Douglas Christopher Stack

License #:

NHA01033 - Active

Category:

Nursing Home Administrator

Issued Date:

Dec 18, 2008

Expiration Date:

Jun 30, 2018

Type:

Nursing Home Administrator

Us Patents

Deoxyamino Acid Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds
view source
US Patent:

6552013, Apr 22, 2003
Filed:

Jun 22, 1999
Appl. No.:

09/338121
Inventors:

James E. Audia - Indianapolis IN
Warren J. Porter - Indianapolis IN
Richard C. Thompson - Frankfort IN
Stephen C. Wilkie - Indianapolis IN
Douglas R. Stack - Fishers IN
Qing Shi - Carmel IN
Assignee:

Elan Pharmaceuticals, Inc. - South San Francisco CA
Eli Lilly and Company - Indianapolis IN
International Classification:

C07D24324
US Classification:

51421204, 51421207, 540522, 540523
Abstract:

Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds
view source
US Patent:

6569851, May 27, 2003
Filed:

Jun 22, 1999
Appl. No.:

09/338191
Inventors:

Richard C. Thompson - Frankfort IN
Stephen Wilkie - Indianapolis IN
Douglas R. Stack - Fishers IN
Eldon E. VanMeter - Greenwood IN
Qing Shi - Carmel IN
Thomas C. Britton - Carmel IN
James E. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
Cynthia L. Cwi - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Martinsville IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN
Assignee:

Elan Pharmaceutials, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:

C07D24324
US Classification:

514219, 514220, 514221, 540509, 540517, 540518, 540558, 540559, 540560, 540561
Abstract:

Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.

Deoxyamino Acid Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting Beta-Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds
view source
US Patent:

6838455, Jan 4, 2005
Filed:

Dec 23, 2002
Appl. No.:

10/326081
Inventors:

James E. Audia - Indianapolis IN, US
Warren J. Porter - Indianapolis IN, US
Richard C. Thompson - Frankfort IN, US
Stephen C. Wilkie - Indianapolis IN, US
Douglas R. Stack - Fishers IN, US
Qing Shi - Carmel IN, US
Assignee:

Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly & Company - Indianapolis IN
International Classification:

C07D48700
C07D49100
C07D48704
C07D24312
A61K 3155
US Classification:

514220, 514221, 540496, 540497, 540498, 540499, 540504, 540517, 540518
Abstract:

Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting Β-Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds
view source
US Patent:

6906056, Jun 14, 2005
Filed:

Mar 20, 2003
Appl. No.:

10/392332
Inventors:

Richard C. Thompson - Frankfort IN, US
Stephen Wilkie - Indianapolis IN, US
Douglas R. Stack - Fishers IN, US
Eldon E. Vanmeter - Greenwood IN, US
Qing Shi - Carmel IN, US
Thomas C. Britton - Carmel IN, US
James E. Audia - Indianapolis IN, US
Jon K. Reel - Carmel IN, US
Thomas E. Mabry - Indianapolis IN, US
Bruce A. Dressman - Indianapolis IN, US
Cynthia L. Cwi - Indianapolis IN, US
Steven S. Henry - New Palestine IN, US
Stacey L. McDaniel - Martinsville IN, US
Russell D. Stucky - Indianapolis IN, US
Warren J. Porter - Indianapolis IN, US
Assignee:

Elan Pharmaceuticals, Inc. - South San Francisco CA
Eli Lilly & Company - Indianapolis IN
International Classification:

C07D267/02
C07D487/00
C07D223/12
A61K031/55
A61P025/28
US Classification:

51421106, 51421203, 51421204, 51421207, 540491, 540522, 540523, 540527
Abstract:

Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Substituted N-Arylpyrrolidines As Selective Androgen Receptor Modulators
view source
US Patent:

7807691, Oct 5, 2010
Filed:

May 10, 2006
Appl. No.:

11/913710
Inventors:

Konstantinos Gavardinas - Monrovia IN, US
Prabhakar Kondaji Jadhav - Zionsville IN, US
Douglas Richard Stack - Fishers IN, US
Assignee:

Eli Lilly and Company - Indianapolis IN
International Classification:

A61K 31/4025
C07D 207/06
C07D 207/08
C07D 207/10
US Classification:

514303, 548577
Abstract:

The present invention provides a compound of the Formula (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising an effective amount of a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly frailty, osteoporosis, osteopenia, and male and female sexual dysfunction comprising administering to a patient in need thereof an effective amount of a compound of Formula (I).

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting Beta-Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds
view source
US Patent:

20050192265, Sep 1, 2005
Filed:

Dec 3, 2004
Appl. No.:

11/002922
Inventors:

Richard Thompson - Frankfort IN, US
Stephen Wilkie - Indianapolis IN, US
Douglas Stack - Fishers IN, US
Eldon Vanmeter - Greenwood IN, US
Qing Shi - Carmel IN, US
Thomas Britton - Carmel IN, US
James Audia - Indianapolis IN, US
Jon Reel - Carmel IN, US
Thomas Mabry - Indianapolis IN, US
Bruce Dressman - Indianapolis IN, US
Cynthia Cwi - Indianapoilis IN, US
Steven Henry - New Palestine IN, US
Stacey McDaniel - Martinsville IN, US
Russell Stucky - Indianapolis IN, US
Warren Porter - Indianapolis IN, US
International Classification:

A61K031/55
A61K031/445
A61K031/473
A61K031/4706
US Classification:

514183000, 514212040, 514212070, 514212080, 514312000, 514327000, 514418000, 514424000, 514284000
Abstract:

Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting Beta-Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds
view source
US Patent:

20050192269, Sep 1, 2005
Filed:

Dec 3, 2004
Appl. No.:

11/002951
Inventors:

Richard Thompson - Frankfort IN, US
Stephen Wilkie - Indianapolis IN, US
Douglas Stack - Fishers IN, US
Eldon Vanmeter - Greenwood IN, US
Qing Shi - Carmel IN, US
Thomas Britton - Carmel IN, US
James Audia - Indianapolis IN, US
Jon Reel - Carmel IN, US
Thomas Mabry - Indianapolis IN, US
Bruce Dressman - Indianapolis IN, US
Cynthia Cwi - Indianapolis IN, US
Steven Henry - New Palestine IN, US
Stacey McDaniel - Martinsville IN, US
Russell Stucky - Indianapolis IN, US
Warren Porter - Indianapolis IN, US
International Classification:

A61K031/55
A61K031/501
A61K031/445
US Classification:

514212010, 514317000, 514424000
Abstract:

Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting Beta-Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds
view source
US Patent:

20050267150, Dec 1, 2005
Filed:

Dec 3, 2004
Appl. No.:

11/002921
Inventors:

Richard Thompson - Frankfort IN, US
Stephen Wilkie - Indianapolis IN, US
Douglas Stack - Fishers IN, US
Eldon Vanmeter - Greenwood IN, US
Qing Shi - Carmel IN, US
Thomas Britton - Carmel IN, US
James Audia - Indianapolis IN, US
Jon Reel - Carmel IN, US
Thomas Mabry - Indianapolis IN, US
Bruce Dressman - Indianapolis IN, US
Cynthia Cwi - Indianapolis IN, US
Steven Henry - New Palestine IN, US
Stacey McDaniel - Martinsville IN, US
Russell Stucky - Indianapolis IN, US
Warren Porter - Indianapolis IN, US
International Classification:

A61K031/4706
A61K031/445
US Classification:

514309000, 514317000, 514312000
Abstract:

Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.